Dow Up 0.08% Nasdaq Up 0.04%

Galena Biopharma, Inc. (GALE)

-NCM
2.42 Up 0.08(3.42%) 2:34PM EDT - Nasdaq Real Time Price
Prev Close:2.34
Open:2.37
Bid:2.43 x 5000
Ask:2.44 x 9100
1y Target Est:5.81
Beta:1.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.00 - 2.63
52wk Range:1.66 - 7.77
Volume:4,992,656
Avg Vol (3m):3,160,470
Market Cap:286.06M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEUp 3.42%286.06M
CELGDown 0.61%76.01B
VSTMDown 1.32%232.32M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback